Description
This Kalorama Information report - Clinical Nutrition - focuses on three primary segments of essential medical nutrition:
Description
STUDY OVERVIEW
Today's market driven environment has made performance assessment of managed market account executives complex and critical. Best Practices, LLC has conducted this in-depth stud...(more)
Description
The Manufacturing and Supply Agreements in Pharma, Biotech and Diagnostics, 2nd edition report provides comprehensive understanding and unprecedented access to the manufacturing and supply agreements ...(more)
Description
Introduction
Drug therapies for immune disorders span an enormous price range—from a few cents per day to tens of thousands
of dollars per year. Not surprisingly, payers impose restricti...(more)
Description
The Oncology Partnering Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the oncology partnering agreements entered into by the wor...(more)
Description
REPORT HIGHTLIGHTS
Description
The report provides a detailed understand and analysis of how and why companies enter co-promotion and co-marketing deals. The majority of deals are multicomponent whereby the licensor retains either ...(more)
Description
The Merger and Acquisition Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the merger and acquisition (M&A) agreements entered int...(more)
Description
The driving force behind revenue in biotechnology and pharmaceutical companies is the product. Since the drugs being sold on the market are the most significant assets these companies own and operate...(more)
Description
Introduction
Long being regarded as an unattractive market, vaccines have re-emerged as successful growth driver for Big Pharma. The launch and rapid uptake of novel, high-price product...(more)
Description
Introduction
This databook provides insight into the top 10 companies in the US life sciences industry in terms of their estimated IT spend.
Scope
Description
Euromonitor International's Eye Care in China report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), allowin...(more)
Description
This report analyzes the global market for Cancer Therapies in US$ Billion. The specific product segments analyzed are Chemotherapy, Targeted Therapy, Hormonal Therapy, and Immunotherapy. Annual forec...(more)
Description
Details the disease states that lead to memory & cognition impairment
Provides forecasts and detail relative to the products available to treat this condition.
Provides definition and ma...(more)
Description This report comprises defined and up to date development strategies for 409 protein kinase drugs (990 projects) within the portfolio of 160 investigators, from Ceased to Marketed. The report extens...(more)
Description
In 2008, Australia’s pharmaceutical market was worth US$6.93bn, it is forecast to reach US$7.28bn in2009 and rise to over US$10bn in 2013, which represents a compound annual growth rate (CAGR) o...(more)
Description
Current economic conditions dominate business strategies. While healthcare has fared better than other industries, it will not be immune from the effects of the current recession. But what aspects o...(more)
Description
The term “companion biomarker” means that a particular diagnostic test is specifically linked to a therapeutic drug either in drug development or in the clinic. Biomarkers of disease have ...(more)
Description
Contraceptives are used for preventing pregnancy and are mainly of two types, hormonal methods and barrier methods, also called as devices. Oral contraceptives account for a major part of the contrace...(more)
Description
Datamonitor's MarketWatch Health Round-up is a one-stop news shop for time-pressed executives. It provides monthly insight into the key events in the Healthcare industry. The report contains the lates...(more)
Description
The Drug Delivery Partnering Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the drug delivery partnering agreements entered into by the worlds...(more)
Description
Espicom’s in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each r...(more)
Description
Espicom’s in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each r...(more)
Description
In BMI’s Q409 Business Environment Ratings (BER) for the 10 markets of the Americas, Chile’scomposite score continued to worsen, with the country now placed eighth overall. Generally speak...(more)
Description
Introduction
Some naysayers disagree, but we regard companion diagnostics as a win-win scenario for all stakeholders.
Companion diagnostics combines drug and diagnostic test development. The p...(more)
Description
The Q409 update of BMI’s Philippines Pharmaceuticals & Healthcare report contains for the first time a10-year forecast for medicine expenditure. The US$2.61bn market is forecast to experience sl...(more)
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
